RIPK3 and Fabry disease: Many of these disrupted signalling pathways likely lead to tissue specific pathological processes observed in FD, such as previously observed Notch1 activation in FD patient kidney biopsies with lyso-Gb3 exposure in podocytes (30) and RIPK3 signalling (15).